| Primary |
| Hypertension |
31.9% |
| Drug Use For Unknown Indication |
24.8% |
| Product Used For Unknown Indication |
11.5% |
| Atrial Fibrillation |
6.2% |
| Blood Pressure Increased |
4.4% |
| Thyroid Disorder |
2.7% |
| Blood Pressure |
1.8% |
| Blood Pressure Management |
1.8% |
| Depression |
1.8% |
| Myocardial Infarction |
1.8% |
| Oesophageal Disorder |
1.8% |
| Prophylaxis Against Transplant Rejection |
1.8% |
| Raynaud's Phenomenon |
1.8% |
| Angina Pectoris |
0.9% |
| Arrhythmia |
0.9% |
| Arthritis |
0.9% |
| Blood Testosterone Decreased |
0.9% |
| Chest Pain |
0.9% |
| Platelet Disorder |
0.9% |
| Tachycardia |
0.9% |
|
| Pharmaceutical Product Complaint |
12.5% |
| Wrong Drug Administered |
9.4% |
| Hypertensive Crisis |
6.3% |
| Hypotension |
6.3% |
| Oedema Peripheral |
6.3% |
| Pollakiuria |
6.3% |
| Scratch |
6.3% |
| Urticaria |
6.3% |
| Vision Blurred |
6.3% |
| Blood Pressure Increased |
3.1% |
| Bradycardia |
3.1% |
| Chronic Obstructive Pulmonary Disease |
3.1% |
| Death |
3.1% |
| Diabetes Mellitus |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Gait Disturbance |
3.1% |
| Gastric Cancer |
3.1% |
| Hospitalisation |
3.1% |
| Hypersensitivity |
3.1% |
| Hypertension |
3.1% |
|
| Secondary |
| Hypertension |
22.0% |
| Atrial Fibrillation |
18.6% |
| Blood Pressure Increased |
16.9% |
| Coronary Artery Disease |
8.5% |
| Drug Use For Unknown Indication |
5.1% |
| Multiple Sclerosis |
4.2% |
| Bipolar I Disorder |
2.5% |
| Cardiac Disorder |
2.5% |
| Demyelination |
2.5% |
| Supplementation Therapy |
2.5% |
| Blood Pressure |
1.7% |
| Blood Pressure Management |
1.7% |
| Bronchitis |
1.7% |
| Erectile Dysfunction |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Raynaud's Phenomenon |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Attention Deficit/hyperactivity Disorder |
0.8% |
| Blood Testosterone Decreased |
0.8% |
| Cardiovascular Event Prophylaxis |
0.8% |
|
| Pharmaceutical Product Complaint |
25.0% |
| Blood Pressure Increased |
10.0% |
| Stomach Discomfort |
7.5% |
| Unevaluable Event |
7.5% |
| Vision Blurred |
7.5% |
| Blood Potassium Increased |
5.0% |
| Heart Rate Irregular |
5.0% |
| Aneurysm |
2.5% |
| Arrhythmia |
2.5% |
| Cardiac Disorder |
2.5% |
| Cough |
2.5% |
| Drug Ineffective |
2.5% |
| Heart Rate Decreased |
2.5% |
| Myocardial Infarction |
2.5% |
| Nasopharyngitis |
2.5% |
| Nausea |
2.5% |
| Oedema Peripheral |
2.5% |
| Presyncope |
2.5% |
| Transient Ischaemic Attack |
2.5% |
| Treatment Noncompliance |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.2% |
| Hypertension |
16.4% |
| Product Used For Unknown Indication |
12.1% |
| Asthma |
4.9% |
| Depression |
4.2% |
| Atrial Fibrillation |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Osteoporosis |
3.5% |
| Blood Cholesterol Increased |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Pain |
2.1% |
| Anxiety |
1.7% |
| Glaucoma |
1.7% |
| Hypothyroidism |
1.7% |
| Prophylaxis |
1.7% |
| Imaging Procedure |
1.5% |
| Breast Cancer |
1.4% |
| Pulmonary Arterial Hypertension |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
|
| Urinary Tract Infection |
12.3% |
| Nausea |
11.1% |
| Vomiting |
8.6% |
| Weight Decreased |
8.6% |
| Dizziness |
4.9% |
| Drug Ineffective |
4.9% |
| Cerebellar Infarction |
3.7% |
| Dyspnoea |
3.7% |
| Hypertension |
3.7% |
| Ill-defined Disorder |
3.7% |
| Injury |
3.7% |
| Ocular Hyperaemia |
3.7% |
| Oedema Peripheral |
3.7% |
| Pancreatitis |
3.7% |
| Pneumonia |
3.7% |
| Pulmonary Congestion |
3.7% |
| Swollen Tongue |
3.7% |
| Therapeutic Response Decreased |
3.7% |
| Anxiety |
2.5% |
| Blood Sodium Increased |
2.5% |
|
